Molecular biology of hepatitis B virus: Effect of nucleotide substitutions on the clinical features of chronic hepatitis B

Medical Molecular Morphology

Volumn 39, Issue 3, 2006, Pages 113-120

  Yokosuka, Osamu ^a   Arai, Makoto ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Genotype; Hepatitis B virus; Lamivudine; Mutation

Indexed keywords

DNA POLYMERASE; DOUBLE STRANDED DNA; HEPATITIS B SURFACE ANTIGEN; NUCLEOTIDE;

CLINICAL FEATURE; DISEASE COURSE; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; VIRUS GENE; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS TRANSMISSION;

BASE PAIRING; BASE SEQUENCE; GENES, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; VIRUS REPLICATION;

EID: 33748953357     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-006-0328-5     Document Type: Review

References (71)

1. J Summers WS Mason 1982 Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate Cell 29 403 415
2. H Okamoto F Tsuda Y Akahane Y Sugai M Yoshiba K Moriyama T Tanaka Y Miyakawa M Mayumi 1994 Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen J Virol 68 8102 8110
3. M Sterneck S Gunther J Gerlach NV Naoumov T Santantonio L Fischer X Rogiers H Greten R Williams H Will 1997 Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis J Hepatol 26 754 764
4. MA Petit S Dubanchet F Capel P Voet C Dauguet P Hauser 1991 HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1 (21-47) Virology 180 483 491
5. D Fernholz PR Galle M Stemler M Brunetto F Bonino H Will 1993 Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier Virology 194 137 148
6. C Trautwein H Schrem HL Tillmann S Kubicka D Walker KH Boker HJ Maschek R Pichlmayr MP Manns 1996 Hepatitis B virus mutations in the pre-S genome before and after liver transplantation Hepatology 24 482 488
7. T Pollicino AR Zanetti I Cacciola MA Petit A Smedile S Campo L Sagliocca M Pasquali E Tanzi G Longo G Raimondo 1997 Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis Hepatology 26 495 499
8. T Santantonio MC Jung R Schneider D Fernholz M Milella L Monno G Pastore GR Pape H Will 1992 Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy Virology 188 948 952
9. H Okamoto F Tsuda H Sakugawa RI Sastrosoewignjo M Imai Y Miyakawa M Mayumi 1988 Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes J Gen Virol 69 pt 10 2575 2583
10. O Yokosuka M Omata K Hosoda M Tada T Ehata M Ohto 1991 Detection and direct sequencing of hepatitis B virus genome by DNA amplification method Gastroenterology 100 175 181
11. E Orito T Ichida H Sakugawa M Sata N Horiike K Hino K Okita T Okanoue S Iino E Tanaka K Suzuki H Watanabe S Hige M Mizokami 2001 Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan Hepatology 34 590 594
12. E Hildt S Urban U Lauer PH Hofschneider AS Kekule 1993 ER-localization and functional expression of the HBV transactivator MHBst Oncogene 8 3359 3367
13. E Hildt G Saher V Bruss PH Hofschneider 1996 The hepatitis B virus large surface protein (LHBs) is a transcriptional activator Virology 225 235 239
14. YF Fan CC Lu WC Chen WJ Yao HC Wang TT Chang HY Lei AL Shiau IJ Su 2001 Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection Hepatology 33 277 286
15. PC Tai FM Suk WH Gerlich AR Neurath C Shih 2002 Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants Virology 292 44 58
16. HC Wang HC Wu CF Chen N Fausto HY Lei IJ Su 2003 Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress Am J Pathol 163 2441 2449
17. HC Wang WT Chang WW Chang HC Wu W Huang HY Lei MD Lai N Fausto IJ Su 2005 Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes Hepatology 41 761 770
18. S Locarnini J McMillan A Bartholomeusz 2003 The hepatitis B virus and common mutants Semin Liver Dis 23 5 20
19. CT Bock S Kubicka MP Manns C Trautwein 1999 Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor Hepatology 29 1236 1247
20. AK Raney HB Le A McLachlan 1992 Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor J Virol 66 6912 6921
21. Y Shaul R Ben-Levy T De-Medina 1986 High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter EMBO J 5 1967 1971
22. WF Carman AR Zanetti P Karayiannis J Waters G Manzillo E Tanzi AJ Zuckerman HC Thomas 1990 Vaccine-induced escape mutant of hepatitis B virus Lancet 336 325 329
23. WF Carman C Trautwein FJ van Deursen K Colman E Dornan G McIntyre J Waters V Kliem R Muller HC Thomas MP Manns 1996 Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis Hepatology 24 489 493
24. U Protzer-Knolle U Naumann R Bartenschlager T Berg U Hopf KH Meyer zum Buschenfelde P Neuhaus G Gerken 1998 Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation Hepatology 27 254 263
25. B Bottcher SA Wynne RA Crowther 1997 Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy Nature (Lond) 386 88 91
26. SA Wynne RA Crowther AG Leslie 1999 The crystal structure of the human hepatitis B virus capsid Mol Cell 3 771 780
27. JF Conway N Cheng A Zlotnick PT Wingfield SJ Stahl AC Steven 1997 Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy Nature (Lond) 386 91 94
28. JF Conway N Cheng A Zlotnick SJ Stahl PT Wingfield DM Belnap U Kanngiesser M Noah AC Steven 1998 Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78 to 83) on the capsid surface, and implications for the distinction between c and e-antigens J Mol Biol 279 1111 1121
29. PP Scaglioni M Melegari JR Wands 1997 Posttranscriptional regulation of hepatitis B virus replication by the precore protein J Virol 71 345 353
30. DR Milich JE Jones JL Hughes J Price AK Raney A McLachlan 1990 Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A 87 6599 6603
31. M Seifer DN Standring 1995 Assembly and antigenicity of hepatitis B virus core particles Intervirology 38 47 62
32. K Takahashi S Kishimoto K Ohori H Yoshizawa A Machida H Ohnuma F Tsuda E Munekata Y Miyakawa M Mayumi 1991 Molecular heterogeneity of e antigen polypeptides in sera from carriers of hepatitis B virus J Immunol 147 3156 3160
33. G Wasenauer J Kock HJ Schlicht 1992 A cysteine and a hydrophobic sequence in the noncleaved portion of the pre-C leader peptide determine the biophysical properties of the secretory core protein (HBe protein) of human hepatitis B virus J Virol 66 5338 5346
34. P MacKay J Lees K Murray 1981 The conversion of hepatitis B core antigen synthesized in E coli into e antigen J Med Virol 8 237 243
35. K Takahashi M Imai T Gotanda T Sano A Oinuma S Mishiro Y Miyakawa M Mayumi 1980 Hepatitis B e antigen polypeptides isolated from sera of individuals infected with hepatitis B virus: comparison with HBeAg polypeptide derived from Dane particles J Gen Virol 50 49 57
36. S Hosono PC Tai W Wang M Ambrose DG Hwang TT Yuan BH Peng CS Yang CS Lee C Shih 1995 Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes Virology 212 151 162
37. T Ehata M Omata O Yokosuka K Hosoda M Ohto 1992 Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection J Clin Invest 89 332 338
38. WL Chuang M Omata T Ehata O Yokosuka Y Ito F Imazeki SN Lu WY Chang M Ohto 1993 Precore mutations and core clustering mutations in chronic hepatitis B virus infection Gastroenterology 104 263 271
39. SL Tsai MH Chen CT Yeh CM Chu AN Lin FH Chiou TH Chang YF Liaw 1996 Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes J Clin Invest 97 577 584
40. WF Carman MR Jacyna S Hadziyannis P Karayiannis MJ McGarvey A Makris HC Thomas 1989 Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection Lancet 2 588 591
41. M Omata T Ehata O Yokosuka K Hosoda M Ohto 1991 Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis N Engl J Med 324 1699 1704
42. T Imamura O Yokosuka T Kurihara T Kanda K Fukai F Imazeki H Saisho 2003 Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba Japan Gut 52 1630 1637
43. T Laskus DH Persing MJ Nowicki JW Mosley J Rakela 1993 Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States Gastroenterology 105 1173 1178
44. H Okamoto S Yotsumoto Y Akahane T Yamanaka Y Miyazaki Y Sugai F Tsuda T Tanaka Y Miyakawa M Mayumi 1990 Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen J Virol 64 1298 1303
45. F Rodriguez-Frias M Buti R Jardi M Cotrina L Viladomiu R Esteban J Guardia 1995 Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations Hepatology 22 1641 1647
46. TT Yuan A Faruqi JW Shih C Shih 1995 The mechanism of natural occurrence of two closely linked HBV precore predominant mutations Virology 211 144 156
47. VE Buckwold Z Xu M Chen TS Yen JH Ou 1996 Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication J Virol 70 5845 5851
48. VE Buckwold Z Xu TS Yen JH Ou 1997 Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication J Gen Virol 78 pt 8 2055 2065
49. J Li Z Xu Y Zheng DL Johnson JH Ou 2002 Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteins J Virol 76 5875 5881
50. K Takahashi Y Ohta K Kanai Y Akahane Y Iwasa K Hino N Ohno H Yoshizawa S Mishiro 1999 Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease Arch Virol 144 1299 1308
51. A Honda O Yokosuka T Ehata M Tagawa F Imazeki H Saisho 1999 Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status J Med Virol 57 337 344
52. T Shaw SA Locarnini 1995 Hepatic purine and pyrimidine metabolism: implications for antiviral chemotherapy of viral hepatitis Liver 15 169 184
53. J Li VE Buckwold MW Hon JH Ou 1999 Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation J Virol 73 1239 1244
54. H Lee HT Kim Y Yun 1998 Liver-specific enhancer II is the target for the p53-mediated inhibition of hepatitis B viral gene expression J Biol Chem 273 19786 19791
55. J Li Ou JH 2001 Differential regulation of hepatitis B virus gene expression by the Sp1 transcription factor J Virol 75 8400 8406
56. H Tu C Bonura C Giannini H Mouly P Soussan M Kew P Paterlini-Brechot C Brechot D Kremsdorf 2001 Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues Cancer Res 61 7803 7810
57. Y Wang SH Lau JS Sham MC Wu T Wang XY Guan 2004 Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis Oncogene 23 142 148
58. G Radziwill W Tucker H Schaller 1990 Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity J Virol 64 613 620
59. R Bartenschlager M Junker-Niepmann H Schaller 1990 The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation J Virol 64 5324 5332
60. R Bartenschlager H Schaller 1992 Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome EMBO J 11 3413 3420
61. JR Pollack D Ganem 1994 Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis J Virol 68 5579 5587
62. K Das X Xiong H Yang CE Westland CS Gibbs SG Sarafianos E Arnold 2001 Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC) J Virol 75 4771 4779
63. T Seta O Yokosuka F Imazeki M Tagawa H Saisho 2000 Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients J Med Virol 60 8 16
64. LJ Stuyver SA Locarnini A Lok DD Richman WF Carman JL Dienstag RF Schinazi 2001 Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region Hepatology 33 751 757
65. MI Allen M Deslauriers CW Andrews GA Tipples KA Walters DL Tyrrell N Brown LD Condreay 1998 Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group Hepatology 27 1670 1677
66. GA Tipples MM Ma KP Fischer VG Bain NM Kneteman DL Tyrrell 1996 Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo Hepatology 24 714 717
67. MF Yuen E Sablon CK Hui HJ Yuan H Decraemer CL Lai 2001 Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy Hepatology 34 785 791
68. SK Ono-Nita N Kato Y Shiratori T Masaki KH Lan FJ Carrilho M Omata 1999 YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: a study by in vitro full-length viral DNA transfection Hepatology 29 939 945
69. SK Ono N Kato Y Shiratori J Kato T Goto RF Schinazi FJ Carrilho M Omata 2001 The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance J Clin Invest 107 449 455
70. J Ding K Das Y Hsiou SG Sarafianos AD Clark Jr A Jacobo-Molina C Tantillo SH Hughes E Arnold 1998 Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution J Mol Biol 284 1095 1111
71. H Huang R Chopra GL Verdine SC Harrison 1998 Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance Science 282 1669 1675